Monitoring Circulating Tumor Cells (CTC) and circulating endothelial Cells (CEC) during Neoadjuvant Combination of Trastuzumab and Bevacizumab with Chemotherapy in HER2 Overexpressing Inflammatory Breast Cancer (IBC) : An Ancillary Study of BEVERLY 2 Multicenter Phase II Trial. J-Y PIERGA et al.